NextCell Pharma AB (OSTO:NXTCL) Preferred Dividends : kr0.00 Mil (TTM As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is NextCell Pharma AB Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. NextCell Pharma AB's preferred dividends for the three months ended in Feb. 2024 was kr0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Feb. 2024 was kr0.00 Mil.

NextCell Pharma AB Preferred Dividends Historical Data

The historical data trend for NextCell Pharma AB's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NextCell Pharma AB Preferred Dividends Chart

NextCell Pharma AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Preferred Dividends

Get a 7-Day Free Trial

NextCell Pharma AB Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

NextCell Pharma AB Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

NextCell Pharma AB (OSTO:NXTCL) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

NextCell Pharma AB (OSTO:NXTCL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NextCell Pharma AB (OSTO:NXTCL) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

65G:Germany

Address

Karolinska Institutet Science Park, Halsovagen 7, Huddinge, SWE, 14157

Website

http://www.nextcellpharma.com

NextCell Pharma AB is a healthcare services provider. The company is engaged in the research of stem cell and is developing the candidate drug ProTrans for the treatment of diabetes and immunosuppression in kidney transplants.

NextCell Pharma AB (OSTO:NXTCL) Headlines

No Headlines